Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Guardant Health stock surges on colon cancer blood test news

Дата публикации: 05-07-2026 15:33:00

Guardant Health (GH) investors have a new number to think about this week.  Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175. Bernstein also kept its Outperform rating intact. The new price target came less than a day after a ...

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Morgan Stanley unveils key Monster stock price prediction6704-07-2026
2Goldman Sachs doubles down on Robinhood stock after record trading surge7805-07-2026
3Top Analyst strongly resets AMD stock price target5705-07-2026
4Top analyst has bold Costco stock outlook for 20260505-07-2026
5Concentra Group Holdings Parent (NYSE:CON) Given New $42.00 Price Target at Royal Bank Of Canada09.6210-08-2026
6Royal Bank Of Canada Boosts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $36.00010.5410-08-2026
7Warren Buffett unveils 11-word stock market warning0505-07-2026
8 Why Palantir’s success will outlast AI exuberance -2305-11-2025
9Jim Cramer makes bold buy call on one booming energy stock7604-07-2026
10Акции "Сегежа груп" на Мосбирже растут более чем на 5% на публикации отчетности0002-11-2021

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 6. Информативность: 7. Источник: www.thestreet.com.